PNC Financial Services Group
XBI icon

PNC Financial Services Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PNC Financial Services Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
89,290
+25,137
+39% +$3.4M 0.01% 506
2026
Q1 		$8.19M Sell
64,153
-8,542
-12% -$1.07M ﹤0.01% 592
2025
Q4 		$8.86M Buy
72,695
+2,168
+3% +$249K ﹤0.01% 577
2025
Q3 		$7.07M Buy
70,527
+26,705
+61% +$2.41M ﹤0.01% 618
2025
Q2 		$3.63M Sell
43,822
-22,656
-34% -$1.81M ﹤0.01% 766
2025
Q1 		$5.39M Sell
66,478
-14,960
-18% -$1.34M ﹤0.01% 641
2024
Q4 		$7.33M Buy
81,438
+4,823
+6% +$467K ﹤0.01% 568
2024
Q3 		$7.57M Sell
76,615
-4,359
-5% -$428K ﹤0.01% 566
2024
Q2 		$7.51M Sell
80,974
-25,519
-24% -$2.29M 0.01% 555
2024
Q1 		$10.1M Buy
106,493
+25,488
+31% +$2.37M 0.01% 514
2023
Q4 		$7.23M Buy
81,005
+2,834
+4% +$210K 0.01% 561
2023
Q3 		$5.71M Sell
78,171
-1,408
-2% -$112K ﹤0.01% 591
2023
Q2 		$6.62M Sell
79,579
-3,124
-4% -$261K 0.01% 575
2023
Q1 		$6.3M Buy
82,703
+5,421
+7% +$450K 0.01% 584
2022
Q4 		$6.41M Buy
77,282
+6,550
+9% +$530K 0.01% 577
2022
Q3 		$5.61M Sell
70,732
-5,525
-7% -$466K 0.01% 596
2022
Q2 		$5.66M Sell
76,257
-8,419
-10% -$632K 0.01% 602
2022
Q1 		$7.61M Sell
84,676
-4,078
-5% -$377K 0.01% 579
2021
Q4 		$9.94M Buy
88,754
+632
+0.7% +$76.2K 0.01% 533
2021
Q3 		$11.1M Sell
88,122
-87
-0.1% -$11.2K 0.01% 492
2021
Q2 		$11.9M Buy
88,209
+6,296
+8% +$828K 0.01% 484
2021
Q1 		$11.1M Sell
81,913
-13,729
-14% -$2.06M 0.01% 481
2020
Q4 		$13.5M Buy
95,642
+20,182
+27% +$2.58M 0.01% 435
2020
Q3 		$8.41M Buy
75,460
+8,966
+13% +$1.01M 0.01% 492
2020
Q2 		$7.44M Buy
66,494
+34,581
+108% +$3.41M 0.01% 498
2020
Q1 		$2.47M Buy
31,913
+5,467
+21% +$484K ﹤0.01% 692
2019
Q4 		$2.52M Buy
26,446
+774
+3% +$67K ﹤0.01% 749
2019
Q3 		$1.96M Buy
25,672
+1,368
+6% +$114K ﹤0.01% 979
2019
Q2 		$2.13M Buy
24,304
+1,021
+4% +$87.1K ﹤0.01% 990
2019
Q1 		$2.11M Buy
23,283
+2,099
+10% +$179K ﹤0.01% 1019
2018
Q4 		$1.52M Sell
21,184
-7,233
-25% -$583K ﹤0.01% 1097
2018
Q3 		$2.72M Buy
28,417
+7,186
+34% +$697K ﹤0.01% 964
2018
Q2 		$2.02M Buy
21,231
+5,629
+36% +$517K ﹤0.01% 1039
2018
Q1 		$1.37M Buy
15,602
+8,055
+107% +$735K ﹤0.01% 1184
2017
Q4 		$640K Sell
7,547
-239
-3% -$20K ﹤0.01% 1525
2017
Q3 		$674K Buy
7,786
+321
+4% +$25.7K ﹤0.01% 1469
2017
Q2 		$576K Buy
7,465
+578
+8% +$41K ﹤0.01% 1540
2017
Q1 		$477K Buy
6,887
+306
+5% +$20.6K ﹤0.01% 1643
2016
Q4 		$390K Sell
6,581
-30,187
-82% -$1.86M ﹤0.01% 1720
2016
Q3 		$2.44M Buy
36,768
+2,368
+7% +$146K ﹤0.01% 899
2016
Q2 		$1.86M Sell
34,400
-156
-0.5% -$8.55K ﹤0.01% 970
2016
Q1 		$1.79M Sell
34,556
-14,774
-30% -$767K ﹤0.01% 994
2015
Q4 		$3.46M Buy
49,330
+5,795
+13% +$395K ﹤0.01% 709
2015
Q3 		$2.71M Buy
43,535
+38,330
+736% +$3.02M ﹤0.01% 809
2015
Q2 		$437K Buy
5,205
+1,989
+62% +$155K ﹤0.01% 1708
2015
Q1 		$242K Buy
3,216
+2,001
+165% +$140K ﹤0.01% 2095
2014
Q4 		$76K Buy
1,215
+75
+7% +$4.28K ﹤0.01% 2615
2014
Q3 		$59K Sell
1,140
-153
-12% -$7.8K ﹤0.01% 2612
2014
Q2 		$66K Sell
1,293
-300
-19% -$13.5K ﹤0.01% 2469
2014
Q1 		$76K Sell
1,593
-858
-35% -$43.9K ﹤0.01% 2332
2013
Q4 		$105K Buy
2,451
+987
+67% +$40.9K ﹤0.01% 2170
2013
Q3 		$63K Buy
1,464
+246
+20% +$9.97K ﹤0.01% 2388
2013
Q2 		$42K Buy
+1,218
New +$42.8K ﹤0.01% 2462

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

PNC Financial Services Group's XBI Position: Q2 2026 in Review

PNC Financial Services Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, buying an estimated $3.4M and bringing the position to 89,290 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #506.

PNC Financial Services Group first reported a position in XBI in Q2 2013 and has held it in 53 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • PNC Financial Services Group held 89,290 shares of State Street SPDR S&P Biotech ETF worth $14.1M as of Q2 2026.
  • PNC Financial Services Group bought 25,137 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.4M.
  • State Street SPDR S&P Biotech ETF made up 0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #506 holding.
  • PNC Financial Services Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 53 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.